CRONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31

Cronos Group Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026

$3.25+0.04 (+1.25%)

Close on Oct 19, 2026

Market cap: $1.22B
P/E (TTM): 16.3
Dividend yield: –

Cronos Group Inc. cash flow statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31
Depreciation & Amortization	14	9.34	8.11	13	15	7.05	4.27	1.94	0.77
Stock-Based Compensation	7.05	8.70	8.77	15	10	15	12	8.15	1.93
Deferred Income Taxes	1.13	-0.27	0.15	-0.24	0.04	0	0	0	0
Other Non-Cash Items	-1.25	0.13	1.92	-1.29	-0.34	0.12	0.05	0.01	–
Change in Accounts Receivable	-17	-0.92	9.21	-2.71	-13	-4.72	-0.57	-2.57	-3.20
Change in Inventory	-10	7.42	7.40	-7.22	12	-0.74	-23	-4.09	-2.50
Change in Accounts Payable	1.11	-7.45	-0.77	-0.86	-1.60	-2.78	-0.05	–	–
Operating Cash Flow	26	19	-43	-89	-154	-145	-131	-7.52	-4.28
Capital Expenditures	-26	-12	-2.51	-3.45	-11	-31	-39	-88	-33
Acquisitions	–	–	–	–	0	0	-224	0	0
Purchase of Investments	-45	0	-608	-271	-230	-201	-300	0	0
Sale & Maturity of Investments	0	186	533	269	215	297	0	–	–
Other Investing Activities	0	0	0.86	0.07	3.03	4.79	0.42	-0.23	–
Investing Cash Flow	-77	175	-59	-1.84	-29	20	-603	-94	-30
Share Repurchases	-9.74	0	0	–	–	–	–	–	–
Taxes Paid on Share-Based Awards	-3.75	-1.23	-1.03	-2.83	-13	-2.15	-0.92	-0.02	0
Other Financing Activities	–	0	0	-0.07	0.02	0.12	–	–	–
Financing Cash Flow	-20	-1.23	-1.03	-2.90	-13	-3.05	1,858	122	39
Foreign Exchange Rate Adjustments	3.59	-3.25	8.01	-29	4.91	6.10	52	-4.09	-0.15
Net Change in Cash	-67	190	-95	-122	-191	-122	1,176	17	4.75
Free Cash Flow	0.15	6.43	-45	-92	-165	-176	-170	-96	-37
Income Taxes Paid	-6.26	0.65	33	0.18	0.89	0	0	–	–
Interest Paid	0	0	0	0	0	0	0.76	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 45.9%
Operating margin: -1.4%
Net margin: 39.1%
Return on equity, FY2025: -0.9%

Financial strength

Current ratio: 16.18
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 828.6%

Valuation

P/E ratio: 16.3
Price to sales: 6.81
Price to book: 1.14
Dividend yield: –